Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease

Abstract
Here we present the crystal structure of SARS-CoV-2 main protease (Mpro) covalently bound to 2-methyl-1-tetralone. This complex was obtained by co-crystallization of Mpro with HEAT (2-(((4-hydroxyphenethyl)amino)methyl)-3,4-dihydronaphthalen-1(2H)-one) in the framework of a large X-ray crystallographic screening project of Mpro against a drug repurposing library, consisting of 5632 approved drugs or compounds in clinical phase trials. Further investigations showed that HEAT is cleaved by Mpro in an E1cB-like reaction mechanism into 2-methylene-1-tetralone and tyramine. The catalytic Cys145 subsequently binds covalently in a Michael addition to the methylene carbon atom of 2-methylene-1-tetralone. According to this postulated model HEAT is acting in a pro-drug-like fashion. It is metabolized by Mpro, followed by covalent binding of one metabolite to the active site. The structure of the covalent adduct elucidated in this study opens up a new path for developing non-peptidic inhibitors.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
Subject Area
- Biochemistry (7346)
- Bioengineering (5323)
- Bioinformatics (20260)
- Biophysics (10016)
- Cancer Biology (7743)
- Cell Biology (11300)
- Clinical Trials (138)
- Developmental Biology (6437)
- Ecology (9951)
- Epidemiology (2065)
- Evolutionary Biology (13321)
- Genetics (9361)
- Genomics (12583)
- Immunology (7701)
- Microbiology (19021)
- Molecular Biology (7441)
- Neuroscience (41036)
- Paleontology (300)
- Pathology (1229)
- Pharmacology and Toxicology (2137)
- Physiology (3160)
- Plant Biology (6860)
- Synthetic Biology (1896)
- Systems Biology (5311)
- Zoology (1089)